Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M Monzó Rausell"'
Autor:
L Lorente Fernández, M Belló Crespo, A Santiuste Roman, M Montero Hernández, M Monzó Rausell, E Soler Company
Publikováno v:
Eur J Hosp Pharm
Background Autologous serum eye drops possess tear-like, antimicrobial and optical properties, and are usually non-allergenic. All these features are responsible for its therapeutic effect. Purpose Describe an adverse reaction attributed to the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9368b4d9602eb3aa1747650aaec7004a
https://europepmc.org/articles/PMC7535811/
https://europepmc.org/articles/PMC7535811/
Autor:
C Sangrador Pelluz, FJ Maiques Llácer, E Soler Company, P Taberner Bonastre, S García Muñoz, M Monzó Rausell
Publikováno v:
European Journal of Hospital Pharmacy. 21:A106.3-A107
Background Telaprevir is used in the treatment of chronic hepatitis C (HCV). Purpose To find out at what point adverse reactions (ADRs) appear from the start of telaprevir treatment in order to prevent harm and improve management. Materials and metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33ed71d43ecc694d2ac9faf545ac3365
https://doi.org/10.1136/ejhpharm-2013-000436.262
https://doi.org/10.1136/ejhpharm-2013-000436.262
Autor:
M Monzó-Rausell, E Soler-Company, A Albert-Mari, C Sangrador-Pelluz, R Olivares-Pallerols, S García-Muñoz
Publikováno v:
European Journal of Hospital Pharmacy. 20:A114.1-A114
Background The use of orally administered anticancer treatment has increased dramatically in the last few years. Patient non-adherence to oral antineoplastic treatment is a barrier to effective treatment. Purpose To estimate adherence and to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6a9472c343305fecc7f18cbd4b35257
https://doi.org/10.1136/ejhpharm-2013-000276.317
https://doi.org/10.1136/ejhpharm-2013-000276.317